do-me/EUR-LEX huggingface dataset:
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 390/02
Date: 2022-10-11
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, health control, health risk, market approval, marketing standard, polishing and scouring preparations








C_2022390EN.01000201.xml










11.10.2022   


EN


Official Journal of the European Union


C 390/2






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 390/02)

Decision granting an authorisation














Reference of the decision
 (2)




Date of decision




Substance name




Holder(s) of the authorisation




Authorisation number




Authorised use




Date of expiry of review period




Reasons for the decision





C(2022) 6922


4 October 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


BioMérieux SA, Chemin de l’Orme, 69280, Marcy-l’Etoile, France


REACH/22/28/0


Industrial use for its non-ionic detergent properties in the formulation of reagents for molecular in vitro preparative and testing applications


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.




REACH/22/28/1


Industrial use for its non-ionic detergent properties in view of controlling the amount of non-specific reactions in the formulation of in vitro reagents for clinical and industrial in-vitro testing immunoassays


4 January 2033




REACH/22/28/2


Industrial use for its non-ionic detergent properties, used for the extraction of biological material which is further formulated and coated on articles intended for clinical and industrial in vitro testing applications


4 January 2025






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).